Publication:

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors

Date

Date

Date
2022
Journal Article
Published version

Citations

Citation copied

Gabryś, H. S., Basler, L., Burgermeister, S., Hogan, S., Ahmadsei, M., Pavic, M., Bogowicz, M., Vuong, D., Tanadini-Lang, S., Förster, R., Kudura, K., Huellner, M., Dummer, R., Levesque, M. P., & Guckenberger, M. (2022). PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Frontiers in Oncology, 12, 977822. https://doi.org/10.3389/fonc.2022.977822

Abstract

Abstract

Abstract

PurposeThis study evaluated pretreatment 2[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT-based radiomic signatures for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibition (ICI).Material and methodFifty-six consecutive metastatic melanoma patients treated with ICI and available imaging were included in the study and 330 metastatic lesions were individually, fully segmented on pre-treatment CT and FDG-PET imaging. Lesion hyperprogression (HPL) was defined as lesion progression according t

Metrics

Downloads

45 since deposited on 2022-12-19
39last week
Acq. date: 2025-11-12

Views

75 since deposited on 2022-12-19
74last week
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

  • Gabryś, H S
    affiliation.icon.alt
  • Basler, Lucas
    affiliation.icon.alt
  • Burgermeister, Simon
    affiliation.icon.alt
  • Hogan, Sabrina
    affiliation.icon.alt
  • Ahmadsei, Maiwand
    affiliation.icon.alt
  • Pavic, Matea
    affiliation.icon.alt
  • Bogowicz, Marta
    affiliation.icon.alt
  • Vuong, Diem
    affiliation.icon.alt
  • Tanadini-Lang, Stephanie
    affiliation.icon.alt
  • Kudura, Ken
    affiliation.icon.alt
  • Huellner, Martin
    affiliation.icon.alt
  • Dummer, Reinhard
    affiliation.icon.alt
  • Levesque, M P
    affiliation.icon.alt
  • Guckenberger, Matthias
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
12

Page range/Item number

Page range/Item number

Page range/Item number
977822

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Cancer Research, Oncology

Language

Language

Language
English

Publication date

Publication date

Publication date
2022-11-24

Date available

Date available

Date available
2022-12-19

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
2234-943X

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

45 since deposited on 2022-12-19
39last week
Acq. date: 2025-11-12

Views

75 since deposited on 2022-12-19
74last week
Acq. date: 2025-11-12

Citations

Citation copied

Gabryś, H. S., Basler, L., Burgermeister, S., Hogan, S., Ahmadsei, M., Pavic, M., Bogowicz, M., Vuong, D., Tanadini-Lang, S., Förster, R., Kudura, K., Huellner, M., Dummer, R., Levesque, M. P., & Guckenberger, M. (2022). PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Frontiers in Oncology, 12, 977822. https://doi.org/10.3389/fonc.2022.977822

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image